A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
Clinical trial NCT06728124 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06728124
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-05-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.